Johnson & Johnson is responding to investigative articles in Reuters and The New York Times about a carcinogen allegedly in the company’s baby powder. Given that J&J has lost several jury verdicts on the issue — one for a whopping $4.69 billion — the company has pulled out the stops to defend itself.
To continue reading this article you must be a CrisisResponsePro subscriber. (CrisisResponsePro subscribers can access the full version by clicking here. ID and password are required.) To take advantage of all of the content, data, and collaborative resources CrisisResponsePro has to offer, contact us at (800) 497-1737, firstname.lastname@example.org, or crisisresponsepro.com/signup.
Photo Credit: Nonowon/Shutterstock